BindingDB logo
myBDB logout

null

SMILES: NCCOCCOCCNC(=O)Cc1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CC#N)CC1

InChI Key:

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 493263   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Tyrosine-protein kinase JAK1 [574-1154]


(Homo sapiens (Human))
BDBM493263
PNG
(N-(2-(2-(2-Aminoethoxy)ethoxy)ethyl)-2-(1-((1r,4r)...)
Show SMILES NCCOCCOCCNC(=O)Cc1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CC#N)CC1 |r,wU:28.31,wD:25.27,(-11.71,.83,;-10.22,.44,;-9.13,1.52,;-7.64,1.13,;-6.55,2.21,;-5.07,1.82,;-3.98,2.91,;-2.49,2.51,;-1.4,3.6,;.09,3.2,;.72,1.8,;-.17,.54,;2.26,1.65,;2.85,.28,;2.22,-1.13,;3.36,-2.16,;3.36,-3.7,;4.7,-4.47,;6.03,-3.7,;7.5,-4.18,;8.4,-2.93,;7.5,-1.69,;6.03,-2.16,;4.7,-1.39,;4.38,.12,;5.47,1.2,;6.95,.81,;8.04,1.89,;7.64,3.38,;8.73,4.47,;10.22,4.07,;11.71,3.67,;6.16,3.78,;5.07,2.69,)|
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.200n/an/an/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
11-point dosing series were made for each compound by serially diluting 1:3 or 1:4 in DMSO, with point 12 being a DMSO control. From the serial dilut...


US Patent US10981911 (2021)


BindingDB Entry DOI: 10.7270/Q27P92G6
More data for this
Ligand-Target Pair
Non-receptor tyrosine-protein kinase TYK2 [580-1182,C936A,C1142A]


(Homo sapiens (Human))
BDBM493263
PNG
(N-(2-(2-(2-Aminoethoxy)ethoxy)ethyl)-2-(1-((1r,4r)...)
Show SMILES NCCOCCOCCNC(=O)Cc1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CC#N)CC1 |r,wU:28.31,wD:25.27,(-11.71,.83,;-10.22,.44,;-9.13,1.52,;-7.64,1.13,;-6.55,2.21,;-5.07,1.82,;-3.98,2.91,;-2.49,2.51,;-1.4,3.6,;.09,3.2,;.72,1.8,;-.17,.54,;2.26,1.65,;2.85,.28,;2.22,-1.13,;3.36,-2.16,;3.36,-3.7,;4.7,-4.47,;6.03,-3.7,;7.5,-4.18,;8.4,-2.93,;7.5,-1.69,;6.03,-2.16,;4.7,-1.39,;4.38,.12,;5.47,1.2,;6.95,.81,;8.04,1.89,;7.64,3.38,;8.73,4.47,;10.22,4.07,;11.71,3.67,;6.16,3.78,;5.07,2.69,)|
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 5.30n/an/an/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
11-point dosing series were made for each compound by serially diluting 1:3 or 1:4 in DMSO, with point 12 being a DMSO control. From the serial dilut...


US Patent US10981911 (2021)


BindingDB Entry DOI: 10.7270/Q27P92G6
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK3 [512-1124]


(Homo sapiens (Human))
BDBM493263
PNG
(N-(2-(2-(2-Aminoethoxy)ethoxy)ethyl)-2-(1-((1r,4r)...)
Show SMILES NCCOCCOCCNC(=O)Cc1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CC#N)CC1 |r,wU:28.31,wD:25.27,(-11.71,.83,;-10.22,.44,;-9.13,1.52,;-7.64,1.13,;-6.55,2.21,;-5.07,1.82,;-3.98,2.91,;-2.49,2.51,;-1.4,3.6,;.09,3.2,;.72,1.8,;-.17,.54,;2.26,1.65,;2.85,.28,;2.22,-1.13,;3.36,-2.16,;3.36,-3.7,;4.7,-4.47,;6.03,-3.7,;7.5,-4.18,;8.4,-2.93,;7.5,-1.69,;6.03,-2.16,;4.7,-1.39,;4.38,.12,;5.47,1.2,;6.95,.81,;8.04,1.89,;7.64,3.38,;8.73,4.47,;10.22,4.07,;11.71,3.67,;6.16,3.78,;5.07,2.69,)|
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 69.5n/an/an/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
11-point dosing series were made for each compound by serially diluting 1:3 or 1:4 in DMSO, with point 12 being a DMSO control. From the serial dilut...


US Patent US10981911 (2021)


BindingDB Entry DOI: 10.7270/Q27P92G6
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2 [532-1132]


(Homo sapiens (Human))
BDBM493263
PNG
(N-(2-(2-(2-Aminoethoxy)ethoxy)ethyl)-2-(1-((1r,4r)...)
Show SMILES NCCOCCOCCNC(=O)Cc1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CC#N)CC1 |r,wU:28.31,wD:25.27,(-11.71,.83,;-10.22,.44,;-9.13,1.52,;-7.64,1.13,;-6.55,2.21,;-5.07,1.82,;-3.98,2.91,;-2.49,2.51,;-1.4,3.6,;.09,3.2,;.72,1.8,;-.17,.54,;2.26,1.65,;2.85,.28,;2.22,-1.13,;3.36,-2.16,;3.36,-3.7,;4.7,-4.47,;6.03,-3.7,;7.5,-4.18,;8.4,-2.93,;7.5,-1.69,;6.03,-2.16,;4.7,-1.39,;4.38,.12,;5.47,1.2,;6.95,.81,;8.04,1.89,;7.64,3.38,;8.73,4.47,;10.22,4.07,;11.71,3.67,;6.16,3.78,;5.07,2.69,)|
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 10.1n/an/an/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
11-point dosing series were made for each compound by serially diluting 1:3 or 1:4 in DMSO, with point 12 being a DMSO control. From the serial dilut...


US Patent US10981911 (2021)


BindingDB Entry DOI: 10.7270/Q27P92G6
More data for this
Ligand-Target Pair